Media & Movies

Lysando Brochure
Lysando Brochure
DOWNLOAD pdf | 16.8 MiB
Lysando ESG
Lysando ESG
DOWNLOAD pdf | 655.0 KiB
Medolysin® Brochure
Medolysin® Brochure
DOWNLOAD pdf | 9.3 MiB
Wound Care and Dermatology Brochure
Wound Care and Dermatology Brochure
DOWNLOAD pdf | 8.0 MiB
Resistant bacteria are on the rise! Artilysin® is our solution to the global health crisis.
1min:17sec
A world without Superbugs: Artilysin® controls bacteria – in a good way!
6min:19sec
Lysando – Breakthrough in Atopic Dermatitis
6min:15sec
X:ENIUS – Viren als Helfer – Phagen als Therapie
25min:47sec
Artilysin against Acinetobacter baumannii
0min:04sec
Artilysin targets P. aeruginosa while S. epidermidis remains unaffected
0min:06sec
Tim McCaffery Appointed as Advisory Board Member at Lysando
Read Article here
Lysando Welcomes Deborah Fleischer to its Advisory Board
Read Article here
Innovation Meets Compassion: Lysando and Bamberg UA Collaborate to Tackle Antibiotic Resistance in Ukrainian Hospitals with Medolysin® Donation
Read Article here
Lysando Welcomes Pharma Leader Dr. Holger Zimmermann to its Advisory Board
Read Article here
LOAD ALL +
Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board
Read Article here
Artilysin® – A Groundbreaking “Green Pharma” Solution
Read Article on Presseportal here
Read Article on Businesswire here
Amicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
Read Article on Presseportal here
Read Article on Businesswire here
Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG
Read Article on Presseportal here
Read Article on Businesswire here
Artilysin®: Promising approach against Acinetobacter baumannii infected wounds
Read Article on Businesswire here
Artilysin®: Fearless Into the Post-antibiotic Era
Read Article on Businesswire here
Lysando AG and Amicogen Inc. Sign General Development Agreement
Read Article on Businesswire here
Dr. Fabian Geldmacher is Director Strategy & Business Development
Read Article on Businesswire here
Wilhelm von Haller is Chief Financial Officer of Lysando AG
Read Article on Businesswire here
Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim
Read Article on Businesswire here
AiCuris announces expansion of its collaboration with Lysando with a focus on diabetic foot infections
Read Article here
AMICOGEN Inc. and Lysando AG bring partnership to the next level with ownership participations in each other’s companies
Read Article on Presseportal here
Read Article on Businesswire here
Lysando AG and AMICOGEN Inc. forge a strategic partnership
Read Article on Businesswire here
Alternative to antibiotics
Read Article here
The search for new antibiotics
Read Article here
Why Artilysin®
ImprintPrivacy

© 2025 Lysando - All rights reserved
Settings saved
Privacy settings

By clicking ‘Accept all’, you consent to the storage of cookies on your local device in accordance with the provisions of the GDPR. This improves navigation on the website and we can see if the site is working as intended. The selection can be customised using the fingerprint displayed.

Privacy Imprint Cookie-Details

user_privacy_settings

Domainname: lysando.com
Expiration: 30 days
Location: Localstorage
Description: Saves the privacy level settings from the cookie consent tool "Privacy Manager".

user_privacy_settings_expires

Domainname: lysando.com
Expiration: 30 days
Location: Localstorage
Description: Saves the storage duration of the privacy level settings from the cookie consent tool "Privacy Manager".

PHPSESSID

Domain name: lysando.com
Expiration: After the end of the session
Storage location: Cookies
Description: Saves technically necessary information about the current session

csrf_https-contao_csrf_token

Domain name: lysando.com
Expiration: After the end of the session
Storage location: Cookies
Description: Created to block CSFR attacks on the current session.

 

Close
You are using an outdated browser. The website may not be displayed correctly.